Suppr超能文献

吸入甲氧明对大鼠气道中P物质诱导的微血管渗漏的抑制作用。

Inhibition of substance P-induced microvascular leakage by inhaled methoxamine in rat airways.

作者信息

Larrazet F, Chauveau M, Weber S, Lockhart A, Frossard N

机构信息

Laboratoire de physiologie respiratoire, UFR Cochin Port-Royal, Paris, France.

出版信息

Br J Pharmacol. 1994 Oct;113(2):649-55. doi: 10.1111/j.1476-5381.1994.tb17039.x.

Abstract
  1. The effect of the inhaled alpha-adrenoceptor agonist, methoxamine (MTX), was studied on experimental airway oedema induced by injection of substance P (SP) in the rat. Sprague-Dawley rats (300-350 g) were anaesthetized with sodium thiopentone, tracheotomized and artificially ventilated. 2. MTX or its vehicle was administered by inhalation. Airway resistance and blood pressure were monitored continuously. Evans Blue dye (EB, 20 mg kg-1) was injected through a jugular catheter 1 min before SP (14.8 nmol kg-1). Airways were dissected out, weighed and placed in formamide for EB extraction and determination by spectrophotometry. 3. EB extravasation induced by SP was significantly reduced in distal intraparenchymal bronchi by inhaled MTX at doses of 50 micrograms kg-1 (58 +/- 9 vs 96 +/- 9 ng EB mg-1 tissue after vehicle, P < 0.001) and 100 micrograms kg-1 (69 +/- 11 vs 137 +/- 26 ng EB mg-1 tissue after vehicle, P < 0.01). Inhaled MTX by itself (100 micrograms kg-1) increased blood pressure: 172 +/- 6 vs 132 +/- 10 mmHg baseline (P < 0.02), but neither induced extravasation nor increased airway resistance. 4. In another set of experiments without SP, MTX was administered intravenously 1 min after EB. At 100 micrograms kg-1, i.v. MTX increased blood pressure to a similar extent as inhaled MTX (180 vs 147 mmHg baseline, P < 0.01), increased airway resistance and caused leakage of plasma proteins in distal intraparenchymal bronchi (79 +/- 7 vs 47 +/- 1 ng EB mg-1 tissue, P < 0.02). 5 Similarly, after sequential i.v. injections of doubling doses of MTX (50-800 microg kg-1), a marked EB extravasation was found in the airways. This was abrogated by pretreatment with prazosin (100 microg kg-1)but not with propranolol (2 mg kg-1).6 These results suggest that microvascular leakage and airway oedema induced by i.v. MTX may be linked to an increase in pressure in the pulmonary circulation, resulting from vasoconstriction of the pulmonary vasculature and acute cardiac dysfunction due to systemic hypertension.7 Our results with inhaled MTX show that direct deposition of MTX at the bronchial vasculature induces a reduction in SP-induced microvascular leakage in rat airways and that inhaled MTX does not share the untoward effect of i.v. MTX inducing airway oedema.
摘要
  1. 研究了吸入性α-肾上腺素能受体激动剂甲氧明(MTX)对大鼠注射P物质(SP)诱导的实验性气道水肿的影响。将体重300 - 350克的Sprague-Dawley大鼠用硫喷妥钠麻醉,进行气管切开并人工通气。

  2. 通过吸入给予MTX或其赋形剂。持续监测气道阻力和血压。在注射SP(14.8纳摩尔/千克)前1分钟,经颈静脉导管注射伊文思蓝染料(EB,20毫克/千克)。解剖出气道,称重后置于甲酰胺中用于EB提取,并通过分光光度法进行测定。

  3. 吸入剂量为50微克/千克(载体给药后组织中EB含量为96±9纳克/毫克,用药后为58±9纳克/毫克,P<0.001)和100微克/千克(载体给药后组织中EB含量为137±26纳克/毫克,用药后为69±11纳克/毫克,P<0.01)的MTX可使SP诱导的EB在肺实质内远端支气管的渗出显著减少。吸入MTX本身(100微克/千克)可使血压升高:基线血压为132±10毫米汞柱,用药后为172±6毫米汞柱(P<0.02),但既不引起渗出也不增加气道阻力。

  4. 在另一组不使用SP的实验中,在注射EB后1分钟静脉注射MTX。静脉注射100微克/千克的MTX使血压升高的程度与吸入MTX相似(基线血压为147毫米汞柱,用药后为180毫米汞柱,P<0.01),增加气道阻力,并导致肺实质内远端支气管血浆蛋白渗漏(载体给药后组织中EB含量为47±1纳克/毫克,用药后为79±7纳克/毫克,P<0.02)。

  5. 同样,在依次静脉注射双倍剂量的MTX(50 - 800微克/千克)后,气道中出现明显的EB渗出。用哌唑嗪(100微克/千克)预处理可消除这种现象,但用普萘洛尔(2毫克/千克)预处理则无效。

  6. 这些结果表明,静脉注射MTX诱导的微血管渗漏和气道水肿可能与肺循环压力升高有关,这是由于肺血管收缩和全身性高血压导致的急性心脏功能障碍所致。

  7. 我们吸入MTX的研究结果表明,MTX直接沉积在支气管血管系统可减少大鼠气道中SP诱导的微血管渗漏,且吸入MTX不具有静脉注射MTX诱导气道水肿的不良作用。

相似文献

本文引用的文献

6
Selective vulnerability of the blood-brain barrier in chemically induced lesions.
J Neuropathol Exp Neurol. 1966 Oct;25(4):542-59. doi: 10.1097/00005072-196610000-00004.
7
The effect of submucosal edema on airways resistance.黏膜下水肿对气道阻力的影响。
Am Rev Respir Dis. 1987 Jun;135(6 Pt 2):S54-6. doi: 10.1164/arrd.1987.135.6P2.S54.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验